Avillion has appointed Ted W. Love a non-executive director
Dr Love was most recently the Executive Vice-President of Research and Development at Onyx Pharmaceuticals, overseeing the successful approval of Kyprolis. Prior to that, he was Chairman and Chief Executive Officer of Nuvelo, Inc., a biopharmaceutical company from March 2001 to January 2009, having been appointed President and Chief Operating Officer in January 2001.
Share
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.